Intervention not reported
Number of patients with premature beat: Qi Lu decoction plus supportive therapy versus supportive therapy alone · patients with viral myocarditis
The intervention showed no clear difference in number of patients with premature beat: Qi Lu decoction plus… (low certainty).
1 finding from 1 review
Intervention not reported
Number of patients with premature beat: Shortscape Fleabane injection plus supportive therapy versus supportive therapy alone · patients with viral myocarditis
The intervention showed no clear difference in number of patients with premature beat: Shortscape Fleabane… (low certainty).
1 finding from 1 review
Intervention not reported
Number of patients with premature beat: Astragaloside injection plus supportive therapy versus supportive therapy alone · patients with viral myocarditis
The intervention showed no clear difference in number of patients with premature beat: Astragaloside injection plus… (low certainty).
1 finding from 1 review
Intervention not reported
Number of patients with premature beat: Compound Qiangqi pill plus supportive therapy versus supportive therapy alone · patients with viral myocarditis
The intervention showed no clear difference in number of patients with premature beat: Compound Qiangqi pill plus… (moderate certainty).
1 finding from 1 review
Intervention not reported
Number of patients with premature beat: Shengmai decoction plus supportive therapy versus supportive therapy alone · patients with viral myocarditis
The intervention showed no clear difference in number of patients with premature beat: Shengmai decoction plus… (moderate certainty).
1 finding from 1 review
Intervention not reported
Number of patients with premature beat: Danhong injection plus supportive therapy versus supportive therapy alone · patients with viral myocarditis
The intervention probably leads to lower number of patients with premature beat: Danhong injection plus… (moderate certainty).
1 finding from 1 review
Intervention not reported
Number of patients with arrhythmia: Astragaloside injection plus supportive therapy versus supportive therapy alone · patients with viral myocarditis
It is very uncertain whether the intervention changes number of patients with arrhythmia: Astragaloside injection plus… (very low certainty).
1 finding from 1 review
Outcomes and · adults with arrhythmias undergoing catheter ablation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Thromboembolic events · adults with arrhythmias undergoing catheter ablation
It is very uncertain whether interrupted changes thromboembolic events compared with uninterrupted anticoagulation therapy (very low certainty).
1 finding from 1 review
Major bleeding · adults with arrhythmias undergoing catheter ablation
Interrupted showed no clear difference in major bleeding compared with uninterrupted anticoagulation therapy (low certainty).
1 finding from 1 review
Composite endpoint of thromboembolic events (stroke or systemic embolism), major bleeding events, and all‐cause mortality · adults with arrhythmias undergoing catheter ablation
Interrupted may leads to lower composite endpoint of thromboembolic events (stroke or systemic… compared with uninterrupted anticoagulation therapy (low certainty).
1 finding from 1 review
Minor bleeding · adults with arrhythmias undergoing catheter ablation
It is very uncertain whether interrupted changes minor bleeding compared with uninterrupted anticoagulation therapy (very low certainty).
1 finding from 1 review
All‐cause mortality · adults with arrhythmias undergoing catheter ablation
Interrupted showed no clear difference in all‐cause mortality compared with uninterrupted anticoagulation therapy (low certainty).
1 finding from 1 review
Asymptomatic thromboembolic events · adults with arrhythmias undergoing catheter ablation
It is very uncertain whether interrupted changes asymptomatic thromboembolic events compared with uninterrupted anticoagulation therapy (very low certainty).
1 finding from 1 review
Percentage of time within the therapeutic range · oral anticoagulant therapy in patients with atrial fibrillation
1 finding from 1 review
Anxiety · oral anticoagulant therapy in patients with atrial fibrillation
1 finding from 1 review
Depression Measured after 52 weeks HADS depression score, 0‐21 points Low score means fewer symptoms · oral anticoagulant therapy in patients with atrial fibrillation
1 finding from 1 review
Decisional conflict · oral anticoagulant therapy in patients with atrial fibrillation
1 finding from 1 review
All‐cause mortality · people with cardiac channelopathies
Implantable cardioverter defibrillators may leads to lower all‐cause mortality compared with β‐blocker therapy (low certainty).
1 finding from 1 review
CVD events: total (fatal and non‐fatal) · people with cardiac channelopathies
Implantable cardioverter defibrillators showed no clear difference in fatal and non‐fatal cardiovascular events compared with β‐blocker therapy (low certainty).
1 finding from 1 review